MedPath

How well the CTscan findings and findings on PET-CT can predict how a patient with NPC will behave

Not Applicable
Completed
Conditions
Health Condition 1: null- Nasopharyngeal Cancer
Registration Number
CTRI/2018/02/011982
Lead Sponsor
A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

All consecutive patients of non-metastatic NPC who have

1. HPR diagnosis of carcinoma nasopharynx.

2. Completed all planned radical treatment with chemo chemochemochemo-radiotherapy radiotherapy radiotherapyradiotherapyradiotherapy radiotherapyradiotherapy at TMH.

3. Baseline FDG-PET.CT with a CECT scan at baseline

4. Post treatment FDG-PET.CT with a CECT scan post treatment.

5. Regular follow up thereafter

Exclusion Criteria

1. Not satisfying above criteria

2. Treatment with Palliative intent.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To correlate anatomic tumor volumes (gross tumor volumes), maximum standardized uptake value (SUV max), metabolic tumor volume (MTV) and total lesional glycolysis (TLG) with event free survival (EFS), distant metastases free survival (DMFS) and overall survival (OS).Timepoint: 4 years
Secondary Outcome Measures
NameTimeMethod
1. To generate volumetric predictive scores that may predict outcomes. <br/ ><br>2. To generate a volumetric prognostic scoring system to predict outcomes. <br/ ><br>3. To correlate metabolic imaging parameters with anatomic imaging parameters.Timepoint: 4 years
© Copyright 2025. All Rights Reserved by MedPath